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Bacteriophages are abundant in human biomes and therefore in human clinical samples. Although this 
is usually not considered, they might interfere with the recovery of bacterial pathogens at two levels: 
1) by propagating in the enrichment cultures used to isolate the infectious agent, causing the lysis of 
the bacterial host and 2) by the detection of bacterial genes inside the phage capsids that mislead the 
presence of the bacterial pathogen. to unravel these interferences, human samples (n = 271) were 
analyzed and infectious phages were observed in 11% of blood culture, 28% of serum, 45% of ascitic 
fluid, 14% of cerebrospinal fluid and 23% of urine samples. The genetic content of phage particles from 
a pool of urine and ascitic fluid samples corresponded to bacteriophages infecting different bacterial 
genera. in addition, many bacterial genes packaged in the phage capsids, including antibiotic resistance 
genes and 16S rRNA genes, were detected in the viromes. Phage interference can be minimized 
applying a simple procedure that reduced the content of phages up to 3 logs while maintaining the 
bacterial load. this method reduced the detection of phage genes avoiding the interference with 
molecular detection of bacteria and reduced the phage propagation in the cultures, enhancing the 
recovery of bacteria up to 6 logs.
Bacteriophages (phages), viruses that infect bacteria1, are probably the most abundant entities in the world2. The 
abundance of phages in the human body is beginning to be envisaged as having a critical influence on human 
health. The ability of phage communities to modify and regulate bacterial communities3,4 suggests that phages are 
to some extent responsible for the homeostasis of the microbiota5,6.
Phages can contribute to bacterial genomic plasticity by horizontal gene transfer (transduction)7,8, which 
may benefit the metabolism9 or affect the virulence of the bacterial host10,11. Some phages produce transducing 
particles consisting of phage capsids that carry only bacterial DNA12,13, these transducing particles or elements 
similar to gene transfer agents (GTAs)14 are thought to be mechanisms used by bacterial cells to spread their own 
genomic content12.
The existence of phages in human biomes presupposes their presence in human samples and their contami-
nation of laboratory cultures initiated from these samples15. This interference can be envisaged at two levels: 1) 
phages may propagate in enriched liquid culture media (used to enhance analytical sensitivity and selectively 
propagate the pathogen) by infecting bacteria (the pathogen targeted for isolation) and causing their lysis during 
the process; and 2) phages can transport bacterial DNA, including virulence genes such as toxins16, antibiotic 
resistance genes (ARG)11,17,18 or bacterial 16S rRNA genes18. If any of these genes are targeted by molecular meth-
ods, positive results can be a confounding factor in the interpretation of results19.
The confirmation of phage interference in microbiological diagnosis, as envisaged in previous studies15,20, 
would represent a serious impediment to the correct detection of bacterial pathogens. It may therefore be useful 
to evaluate strategies that allow the removal of phages from the human samples without interfering with bacte-
rial recovery or entailing an unacceptable increase in time, efforts and costs. The aim of the present study was to 
address these issues.
1Department of Genetics, Microbiology and Statistics, University of Barcelona, Diagonal 643, Annex, Floor 0, 08028, 
Barcelona, Spain. 2European Genome-phenome Archive, Centre for Genomic Regulation (CRG), Doctor Aiguader 
88, 08003, Barcelona, Spain. 3Servei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Institut d’Investigació 
Biomèdica Sant Pau, Sant Quintí 89, 08041, Barcelona, Spain. 4Departament de Genètica i de Microbiologia, 
Universitat Autònoma de Barcelona, Barcelona, Spain. ✉e-mail: mmuniesa@ub.edu
open
2Scientific RepoRtS |         (2020) 10:6737  | https://doi.org/10.1038/s41598-020-63432-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Results
Detection of phages in human samples. Phages were detected in all sample types analyzed, first by 
infectivity assays (Table 1). Between 40–57% of all sample types contained phages able to infect Escherichia coli 
WG5, with the exception of blood (13.5%). Lysis plaques were not observed in any of the other bacterial species 
tested (Bacteroides fragilis, Enterococcus faecalis and Pseudomonas aeruginosa).
Later, confirmation of the phage particles obtained from samples showing positive lysis on E. coli was con-
ducted by Transmission Electron Microscopy (TEM). TEM observation of phages directly isolated from the sam-
ples was performed in those samples containing more than 107–108 phage particles/mL, the minimal required 
for TEM visualization13. Below this concentration no phage particles will be observed. When phages were not so 
abundant and therefore not observed by direct analysis, they were then recovered from the lysis plaques generated 
on E. coli. Nevertheless, despite our efforts to increase the amount of particles, some samples showing plaques of 
lysis on E. coli did not allow observation by TEM.
The lowest phage detection rate by TEM was in blood samples (11.5%), while serum, a priori a sample 
expected to produce similar results, showed higher percentages in both analyses (infectivity and TEM). On aver-
age, infectious phages were observed in 42.1% of the samples and in the 28.4% of them it was possible to visualize 
phage particles by TEM (Table 1).
Myoviridae, Siphoviridae (the most frequent), and Podoviridae21 phage morphological types were observed. 
Many samples showed icosahedral capsids of 40–60 nm of diameter compatible with these three groups but with-
out a tail, which made them indistinguishable (Fig. 1). In two cerebrospinal fluid (CSF) samples (25%), filaments 
compatible with phages of the Inoviridae morphological type were observed (Table 1).
Virome analysis. Four pools of urine samples and one pool of ascitic fluid (AF) samples allowed the recov-
ery of viral DNA in sufficient quantity and purity to generate the libraries. Before the capsids were broken, the 
samples were tested for 16S rRNA genes, and negative results confirmed the absence of non-packaged DNA and 
the effectiveness of the protocol18. Analysis of the virome showed a great number of unclassified sequences, that 
was greater in the AF and in two urine pool samples (Table 2), but the abundance of unclassified sequences did 
not correlate with the number of phages detected. The viromes confirmed the presence of bacteriophages in the 
samples and revealed coincidences with phages infecting different bacterial genera (Table 2; Fig. 2). Even if the 
identification of phage sequences by Kraken suggests a possible bacterial host, this cannot be confirmed only by 
sequence comparison with the databases. Nevertheless, all samples showed sequences of phages coincident with 
phages infecting Propionibacterium and Staphylococcus, and all samples showed the presence of CrAssphage, a 
human-specific phage first detected in silico22 that infects the genus Bacteroides. Viruses other than bacterio-
phages were detected in the viromes, being a poxvirus (BeAn 58058 virus)23, human endogenous retrovirus and 
polyomaviruses the most frequently found in ascetic fluid. The latter ones, papillomaviruses and adenoviruses 
were the most frequently detected in the urine viromes.
Siphoviridae was the most abundant morphological type identified in phageomes, followed by Myoviridae. 
Virome 12 showed 89% of Siphoviridae and 9% of Myoviridae; virome 14 showed 87.5% Siphoviridae and 7.8% 
Myoviridae, virome 15 shows 85.1% Siphoviridae and 6.4% Myoviridae, virome 16 showed 88.6% Siphoviridae and 
9.1% Myoviridae and virome 17 showed 75.9% of Siphoviridae and 13.8% Myoviridae. There was a lower presence 
of Podoviridae and unclassified morphology that corresponded mostly to CrAssphage viruses.
Bacterial genes in the virome. The five viromes analyzed (12, 14–17) showed bacterial DNA in the 
unassembled reads and in the contigs. While the bacterial DNA contamination during the viral DNA extrac-
tion was excluded by the controls used, the possibility of bacterial DNA contamination during the sequencing 
process was also excluded by the negative samples. Moreover, human sequences were not found in our viromes 
as should be expectable in case of contamination. Considering all this, we concluded that the bacterial DNA 
identified should be located within the phage capsids. We observed a great diversity of 16S rRNA gene sequences 
from different bacterial groups in contigs of different lengths (from 250 bp to various hundreds of bp) (Table 3; 
Fig. 2). Comparison of viromes of the four urine samples revealed that they shared some bacterial 16S rRNA gene 
sequences. Some bacterial genera to which this 16S rRNA gene belonged matched the hosts of the bacteriophages 
detected in the samples (Fig. 2, black bars). Other phages did not match the 16S rRNA gene sequences found in 
Ascitic fluid Blood Serum CSF Urine Total
N° of samples (individuals) 60 135 (52) 50 56 65 (53) 366 (271)
With phages showing infectivity on E. coli WG5 (%)* 34 (56.7) 7(13.5) 25 (50) 27(48.2) 21(39.6) 114 (42.1)
With phages showing infectivity and observed by TEM (%) 27 (45) 6 (11.5) 14 (28) 8 (14.3) 12 (22.6) 77 (28.4)
% Myoviridae 0 0 0 0 8.3 1.5
% Siphoviridae 51.9 50 51.9 12.5 16.7 41.8
% Podoviridae 18.5 16.7 18.5 37.5 8.3 20.9
% Capsid with no tail 29.6 33.3 29.6 25 66.7 32.8
% Inoviridae 0 0 0 25 0 3.0
Table 1. Human samples in which bacteriophages were detected. CSF: Cerebrospinal fluid. *Only detected with 
E. coli WG5, with B. fragilis, P. aeruginosa and E. faecalis were not observed.
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the viromes, for example, Aeromonas, Bacillus or Caulobacter phages in the AF, and Brocothirx, Prochlorococcus, 
Listeria, Mycobacterium and Enterococcus phages in urines.
The viromes also contained a diverse range of ARGs, conferring resistance to aminoglycosides, β-lactams, 
fosfomycin, macrolides, phenicols, quinolones, sulfonamides, tetracyclines or trimethoprim (Table 3). Only those 
genes with a minimal identity of 97% in at least 60% of the sequence were defined as ARGs. The analysis of ARG 
flanking showed that most ARGs were located in bacterial genomes (plasmids or chromosome), and only one 
virome (#17) was found to contain genes conferring resistance to aminoglycosides (aph(3′)-III and ant(6)-Ia) and 
to macrolides (ermB) located in a Streptococcus phage genome (GenBank: KT336321.1), although these genes also 
blasted against the Enterococcus chromosome.
interference of phages with the molecular detection of bacteria. The elimination of phages 
from the samples was explored with the aim of finding a methodology that allows phage reduction without 
Figure 1. Electron micrographs of phages from ascetic fluid, blood, serum, cerebrospinal fluid (CSF) and urine. 
(M) Myoviridae, (S) Siphoviridae, (P) Podoviridae, (I) Inoviridae and (NT) structures compatible with phage 







Nº of reads (Nº 
nucleotides)
Nº of contigs (Nº 
nucleotides)
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contigs (%)




phages Possible phage host (number of phages)*




(54.41 Mbp) 2774 (1.48%) 184955 (98.52%) 35
Aeromonas (1), Bacillus (2), Caulobacter (1), Clostridium 
(1), Halocyntia (1), Propionibacteium (22), Salmonella (1), 
Staphylococcus (1), Streptococcus (1), Vibrio (2), Yersinia (1), 
crAssphage** (1)
14 17 urines 50078697 (13973.96 Mbp)
170329  
(60.57 Mbp) 15491 (9.09%) 154838 (90.91%) 64
Brochothrix (1), Enterobacteria (1), Erwinia (3), Escherichia (7) 
Pantoea (1), Salmonella (5), Enterococcus (1), Mycobacterium (1), 
Prochlorococcus (1), Propionibacterium (36), Pseudomonas (1), 
Staphylococcus (4), Streptococcus (1), crAssphage (1)
15 21 urines 3516412 (999.81 Mbp)
35005  
(14.99 Mbp) 17188 (49.10%) 17817 (50.90%) 47
Aeromonas (1), Bacillus (1), Enterococcus (2), Lactobacillus (4), 
Lactococcus (1), Listeria (1), Mycobacterium (1), Propionibacterium 
(29), Rhizobium (1), Staphylococcus (1), Streptococcus (5), 
crAssphage (1)
16 15 urines 4867915 (1359.94 Mbp)
30101  
(20.00 Mbp) 22117 (73.48%) 7984 (26.52%) 44
Enterobacteria (1) Edwardsiella (1), Escherichia (3), Salmonella 
(1), Enterococcus (1), Lactobacillus (4), Propionibacteium (30), 
Staphylococcus (2), crAssphage (1)
17 6 urines 14093699 (3501.02 Mbp)
131414  
(51.45 Mbp) 5362 (4.08%) 126052 (95.92%) 29
Bacillus (1), Bacteroides (1), Enterococcus (1), Lactobacillus (3), 
Propionibacterium (18), Staphylococcus (4), crAssphage (1)
Table 2. Viromes of the human samples and bacterial genes detected. *Number of different phages detected 
in each virome that show homology with sequences in the databases of phages infecting the bacterial host 
described. **crAssphage is a particular type of human-specific phage infecting Bacteroides genera.
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disturbing bacterial recovery, a methodology that is suitable for routine use and has a minimal cost. Phages 
were removed physically by membrane filtration using DURAPORE membranes of 0.45 μm pore size. These 
low-protein-binding membranes allowed phage particles to pass through while retaining bacteria. To verify that 
phages had been physically removed from the samples, first a specific qPCR was performed targeting a Stx phage. 
Urine, AF and serum samples were spiked with 104 Stx phage particles (assuming that each phage carries one 
stx copy, the GC (gene copy) value is equivalent to the number of phages carrying stx) (Fig. 3). After filtration, a 
significant (p < 0.05) reduction from 2.17 to 3.22 log10 units in the number of Stx phages was observed in all the 
samples analyzed and in all three independent replicates (Fig. 3).
Bacterial strain recovery. Urine, AF and serum samples containing E. coli or P. aeruginosa and their 
respective phages were processed with and without filtration. The influence of the filtration method on bacterial 
recovery was evaluated by comparing samples on an enrichment culture incubated for 18 h at 37 °C before and 
after processing (Table 4, Fig. 4).
A significant reduction of 2–3 log10 PFU/mL was achieved for both E. coli and P. aeruginosa phages (Table 4, 
Fig. 4A) without affecting the bacterial recovery (Table 4). After incubation, the bacterial counts in filtered (F) 
samples were significantly (p < 0.05) higher than in the non-filtered (NF) samples (Fig. 4B). E. coli showed greater 
differences between F and NF samples than P. aeruginosa, suggesting higher rates of coliphage propagation in E. 
coli strain WG5. A difference in recovery was not attributable to the different matrices.
Discussion
In a previous study by our group, infectious bacteriophages were found in a limited set of urine and AF samples, 
resulting in phage interference with the isolation of the bacterial pathogen15. In the current study, a greater abun-
dance of phages was detected in a wider range of human samples, indicating the presence of phages not only in 
urine and AF, but also in blood-sera and CSF with variable prevalence. While the detection of phages in animal 
serum samples was reported some time ago24, and confirmed by metagenomics of blood25, to our knowledge this 
is the first report of infectious phages in CSF of humans. A recent study of CSF in patients receiving hematopoie-
tic stem cell transplantation showed contigs mapped to phages26, although it is not clear whether the phages were 
already present in the patients, acquired after transplantation, or indeed if the CSF contained phages or remnant 
phage DNA.
Figure 2. Identification of the 16S rRNA gene sequences found in the virome of a pool of ascitic fluids, and 
four pools of urine samples. On the left side of the chart: 16S rRNA gene sequences of diverse bacterial genera 
identified in the viromes. On the right side of the chart, bars indicate the coincidence with sequences of 
bacteriophages infecting particular bacterial groups. The length of the bars corresponds to the length of the 
contig in base pairs (bp). In the urine samples, next to each bacterial group and in brackets is shown the number 
of urine viromes in which the 16S rRNA gene sequence of each genus was detected.
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The lowest percentage of phage detection was in blood samples, whereas nearly 50% of serum samples con-
tained infectious phages. Although serum and blood samples are essentially the same, the blood samples were 
diluted in blood culture bottles prior to analysis, whereas sera were not. Moreover, blood is more difficult to 
handle, particularly for filtration through the membranes, which became clogged due to the high density of the 
Virome
N° of 16S rRNA 
gene*
N° 
ARG* Antibiotic and resistance genes (bp) ARG flanking region
12 78 1 Tetracyclines: tetC (1013) P: Salmonella
14 96 15 Aminoglycosides: aph(3”)-Ib (804), aadA5 (789), aph(6)-Id (831) P: E. coli or Klebsiella
β-lactams: blaOXA-396 (789), blaTEM-1B (860), 
blaPAO (1194)
C: Pseudomonas
Fosfomycin: fosa (408) C: Pseudomonas
Macrolides: mdfA (1233), mphA (906) P: E. coli
Quinolones: crpP (198) C: Pseudomonas
Sulfonamides: sul1 (840), sul2 (816) P: E. coli
Tetracyclines: tetC (923), tetA (1200) P: Salmonella or Vibrio
Trimethoprim: dfrA17 (474) P: E. coli
15 45 6 Aminoglycosides: aadA1 (758), aadA2 (792) P: E. coli or Klebsiella
β-lactams: blaTEM-116 (861)
C: Propionibacterium or 
Mycoplasma
Phenicols: cmlA1 (1260) P: E. coli or Klebsiella
Sulfonamides: sul3 (792) P: E. coli, C: Salmonella
Tetracyclines: tetA (1200) P: E. coli
16 37 14 Aminoglycosides: aac(3)-IIa (861), aph(6)-Id (796), aph(3”)-Ib (521)
P: E. coli. C: Klebsiella or 
Rheinheimera
β-lactams: blaPAO (1182), blaCTX-M-28 (540), 
blaTEM-1B (733)
C: Pseudomonas or Klebsiella. P: 
E. coli
Fosfomycin: catB7 (522), catB3 (442) C: Pseudomonas
Quinolones: oqxA (1151),qnrB1 (645), fosA 
(366)
C: Klebsiella, Citrobacter or 
Salmonella
Tetracyclines: tetA (1015) P: E. coli, Klebsiella, Salmonella, Shigella
Trimethoprim: dfrA14 (474) P: Klebsiella
17 73 10 Aminoglycosides: aph(3’)-III (795), ant(6)-Ia (909), aac(6’)-Ii (549)
PH: Streptococcus phage C: 
Enterococcus
Macrolides: mdfA (1233), msrC (1479), 
ermB (738), ermT (544)
PH: Streptococcus phage C: 
Enterococcus
Tetracyclines: tetM (1225), tetL (1343) C: Enterococcus, Staphylococcus
Trimethoprim: dfrG (498) C: Enterococcus
Table 3. Bacterial genes detected in the virome of the samples. P: Plasmid, C: Chromosome, PH: Phage genome 
*Number of different 16S rRNA genes or different ARGs that were detected in each virome as verified by 
Kraken.
Figure 3. Phage reduction (log10 gene copy [GC]) of the Stx phage after filtration through 0.45 μm low-protein-
binding polyvinylidene fluoride membranes (F) versus non-filtered samples (NF). The results correspond to 
three independent experiments on each matrix.
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samples. When blood was analyzed by TEM, a large number of particles of undefined nature were visible, which 
interfered with phage visualization and identification. As only clearly recognizable phage capsids were taken into 
account, a large number of phages in the blood probably remained undetected. In contrast, serum samples were 
more concentrated and easier to handle than blood, and phage prevalence detected in sera was markedly higher. 
The Siphoviridae morphological type was the most common group, as previously reported15,18,27. Siphoviridae 
detection could have been underestimated in a percentage of samples showing icosahedral phage capsids compat-
ible with Siphoviridae morphology but without a tail, which prevented their correct classification18,28–30.
The wide range of phage hosts restricts their detection by culture. For example despite detecting phages of 
Bacteroides, Enterococcus or Pseudomonas in the viromes, phages infecting some strains of these bacterial gen-
era have not been detected in this study. Moreover, phage detection by microscopy is limited by the density of 
phage particles (since TEM requires a minimum of 107–8 phage particles). In contrast, a more detailed picture of 
the diversity of phages in the samples was provided by the virome analysis. The multi-step phage DNA purifi-
cation protocol was previously validated to guarantee that only DNA within viral capsids was evaluated18. This 
procedure, together with the limited number of phages in some of the samples, meant that sufficient DNA con-
centration and purity for the metagenomic analysis was only obtained in five pools of samples. Nevertheless, the 
viromes analyzed showed a far greater abundance of phages infecting a wider range of bacterial genera than in 
our previous study18. Phage identification was based on Kraken results, which in turn were based on database 
sequences. Therefore, the homology with an entry of a phage infecting a particular bacterial genus does not 
confirm that the bacterial host of this phage has been identified; it only indicates a potential host. Virus-host 
assignment is one of the most challenging issues when working with metaviromes and results obtained should be 
only considered as a match with the information in the databases. Genome similarity between different phages31 
and the limited sequence data available for phages may have resulted in an underestimation or misidentifica-
tion of phages, as a fraction of contigs were not classified. Surprisingly, some phage sequences in our viromes 
matched with phages infecting environmental bacteria. Moreover, the 16S rRNA genes of these bacterial groups 
E. coli P. aeruginosa
Urine Ascitic Fluid Serum Urine Ascitic Fluid Serum
Average phage counts F 6.50 × 10
2  
(1.58 × 102)
1.60 × 102  
(1.89 × 102)
2.33 × 102  
(1.44 × 102)
1.63 × 102  
(7.77 × 101)
6.67 × 101  
(2.89 × 101)
6.33 × 101 
(1.58 × 101)
NF 1.03 × 10
5  
(1.00 × 104)
1.18 × 105  
(6.66 × 103)
1.63 × 105  
(8.96 × 103)
7.10 × 104  
(1.95 × 104)
6.42 × 104  
(1.74 × 104)
4.33 × 104 
(7.57 × 103)
Average bacterial counts F 7.67 × 10
1  
(4.04 × 101)
4.63 × 102  
(3.09 × 101)
1.75 × 102  
(1.06 × 101)
8.00 × 101  
(8.66 × 101)
1.57 × 102  
(1.00 × 102)
1.07 × 102 
(3.66 × 101)
NF 9.50 × 10
1  
(8.66 × 100)
2.25 × 102  
(9.57 × 100)
1.83 × 102  
(7.64 × 100)
1.17 × 102  
(2.89 × 101)
3.37 × 102  
(1.04 × 102)
1.13 × 102 
(4.54 × 101)
Table 4. Values of phage (PFU/mL) and bacteria (CFU/mL) in the samples after the application of the filtration 
method (F) in comparison with the non-filtered controls (NF). In brackets, standard deviation.
Figure 4. Phages can bias the outcome of enrichment cultures. (A) Reduction (log10 PFU/mL) of phages 
infecting E. coli and P. aeruginosa in urine, AF and serum samples after the filtration procedure. (B) Recovery 
of culturable E. coli and P. aeruginosa (log10 CFU/mL) in enrichment cultures of urine, AF and serum samples 
with (F) and without (NF) the filtration procedure. The results shown are the average of three independent 
experiments and error bars indicate the standard deviation.
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have also been detected. Although unexpected, marine bacteria, Rizhobium or plant pathogens have previously 
been reported in gut, urine or ascitic metagenomes32–36. Accordingly, the detection of phage sequences matching 
with phages infecting these bacterial groups becomes more reasonable. These bacterial species and their phages 
could have been acquired through the diet or by cross-contamination between human biomes (e.g fecal-ascites, 
fecal-urine). It may also happen that there is an incorrect identification caused by similar viral sequences in the 
databases.
Viruses other than phages detected in the viromes were not as diverse or as abundant as phages, but this could 
be caused by the absence of infectious viruses in the samples if there was no viral infection and/or by the lower 
densities of animal viruses in comparison with the densities of bacteriophages, as previously reported30,37.
As in the case of serum and blood, the inherently sterile CSF and AF could have been expected to give similar 
results. Yet considerable differences were observed, with AF giving the highest percentage of positive samples and 
CSF the lowest after blood. This indicates that translocation of bacteria and/or phages may occur between the 
digestive tract and peritoneal fluid, even spontaneously, and to a greater extent in patients with ascites. This trans-
location may be easier for virus particles than for bacteria15,37. On the contrary, CSF is protected by the meninges 
and is located further away from highly contaminated regions such as the digestive tract.
In the case of urine, classically considered as sterile, it is exposed to contamination by the flora of the distal 
urethra, vagina and/or perineum during collection. Whether the phages in urine samples proceed from the uri-
nary tract or the collection process, their presence can interfere with bacteriological analysis.
The presence of phages in a human sample has further implications when bacterial detection is based on tar-
geting a specific gene, for instance, eubacterial 16S rRNA genes. Phages incorporate bacterial genes through lat-
eral12, generalized7 and specialized transduction7,37. Regardless of the mechanism, phage particles packaging 16S 
rRNA genes have been reported in fecal phageomes18. Since DNA extraction methods do not distinguish between 
phage and bacterial DNA38, the presence of phage DNA complicates pathogen identification or produces false 
positives. In this study, the diversity of 16S rRNA gene sequences in phage particles greatly exceeded the range of 
identified phages (Fig. 2), which may be explained by the higher number of bacterial 16S rRNA gene sequences in 
the genomic databases in comparison with the short repertoire of available phage genomes.
The bacterial genes identified in the viromes included ARGs, which are among the most relevant genes mobi-
lized in phage capsids. The implications of this mobilization go beyond incorrect molecular detection, as it con-
firms that phage particles, by acting as vehicles for gene transfer and transduction, are a mechanism for the spread 
of ARGs39–41. The ARG flanking regions corroborated that phage particles contained mostly bacterial and only in 
a few cases phage DNA13,18,42.
The size of phages allows them to be removed easily by relatively cost-efficient protocols. In the present study, 
membrane filtration reduced phage particles without disturbing bacterial recovery and favored bacterial isolation 
by impeding phage propagation and bacterial lysis. These results confirm previous observations, in which E. coli 
was isolated from agar plates from AF samples containing phages, but not after enrichment in liquid cultures15.
Phage abundance in human samples is highly variable, so it is not always a key factor in bacterial recovery 
and/or identification. However, when abundant, phages can clearly interfere with diagnosis at different levels. The 
occurrence of phages in the human body was unsuspected until relatively recently. Now that their prevalence in 
human biomes has been demonstrated, this knowledge should be reflected in microbiological diagnosis by the 
incorporation of suitable protocols.
Methods
Samples. A total of 366 samples from 271 individuals were analyzed: 135 blood culture vials (referred to 
henceforth as blood) from 52 individuals, 65 urine samples from 53 individuals, 60 ascitic fluid (AF) samples 
from 60 individuals, 56 cerebrospinal fluid (CSF) samples from 56 individuals and 50 serums from 50 individ-
uals. All samples were obtained from the Microbiology Laboratory of the Hospital de la Santa Creu i Sant Pau 
(Barcelona, Spain) and were used after performing a conventional microbiological diagnosis.
All methods were carried out in accordance with official ethics regulations (Biomedical Research Law 14/2007, 
of July 3rd, and the provisions of Royal Decree 1716/2011, of 18th November) (http://www.eurecnet.org/legisla-
tion/spain.html), which establishes the treatment of biological samples of human origin for biomedical research 
purposes. The procedures were approved by the Clinical Research Ethics Committee (CEIC) of the Biomedical 
Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), Barcelona, Spain. Approval of the 
Ethics Committee included the exemption of obtaining the informed consent of the participants considering 
that samples were completely anonymized, that no data on the patients were collected and that samples were not 
stored but were destroyed immediately after the study.
Detection of phages in the samples. 5 mL of each sample was used for phage purification as previously 
described15. If the volume was insufficient (as in the case of CSF), it was raised to 2 mL with phosphate buffer 
saline (PBS). Samples were filtered through low protein-binding 0.22-µm-pore-size membrane filters (Millex-GP, 
Millipore, Bedford, MA), treated with chloroform (1:10), vortexed for 2 min and centrifuged at 16 000xg for 
5 min, and then the supernatant was collected.
Phages were evaluated for infectivity using strains Escherichia coli WG543, Bacteroides fragilis RYC205644, 
Enterococcus faecalis ATCC 29212 and Pseudomonas aeruginosa 9108 as hosts by the double agar layer method1.
Transmission electron microscopy (TEM) studies. 10 µl of phage suspensions were dropped onto cop-
per grids with carbon-coated Formvar films, negatively stained with 2% ammonium molybdate (pH 6.8) and 
examined under a Jeol 1010 transmission electron microscope (JEOL Inc. Peabody, MA) operating at 80 kV.
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Virome analysis. Four pools of urine samples and one pool of AF samples (comprising between 6 and 
21 samples) (Table 2) selected among those that showed presence of bacteriophages in the previous experi-
ments were pooled to obtain viral DNA in sufficient quantity and purity to generate the libraries. Viral DNA 
was extracted as previously described18. Briefly, samples were filtered by 0.22-µm-pore-size membrane filters 
(Millex-GP, Millipore), 20-fold concentrated using protein concentrators, chloroform-treated to break possi-
ble vesicles and digested with DNase I (100 units/mL; Sigma-Aldrich, Spain) for 1 hour at 37 °C to eliminate 
non-packaged DNA. The DNase was inactivated by heating the suspension at 70 °C for 10 minutes. The absence 
of non-packaged bacterial DNA was verified by real time qPCR amplification of eubacterial 16S rRNA gene13,18. 
These controls are expected to be negative if the protocol successfully eliminates most of the vesicles and DNA 
outside the viral capsids. Controls were applied to verify absence of inhibitors and correct DNase inactivation as 
in previous studies18,45. Briefly, after DNAse inactivation 103 GC of blaTEM gene were added to the controls and 
amplified by qPCR. An incomplete DNase inactivation, or the presence of inhibitors, would have resulted in a 
lower number of blaTEM GC which was not observed.
Packaged DNA was extracted using a PowerSoil® DNA isolation kit (Qiagen Iberia, Barcelona. Spain).
Sequencing was performed as previously described using Illumina libraries generated following the 
Nextera XT (Illumina, Inc., San Diego, CA, US) manufacturer’s protocol for paired-end libraries (2 × 150 bp)18. 
Bioinformatic analysis to identify phages in the virome and bacterial genes was performed as previously 
described18.
Sequence reads were quality checked with FASTQC v0.11.2 to detect any anomalies in the sequencing process. 
Raw data obtained from sequencing were processed with Trimmomatic (v0.36)46. Clean reads were acquired by 
removing low-quality reads, sequences with N ratio >3%, and adapter sequences in reads. Reads were then de 
novo assembled with default parameters (k-mer sizes 21, 33, 55, 77 and 91) using SPAdes v3.1347. Contigs were 
classified taxonomically with Kraken v0.10.548. ARGs were searched with ResFinder 3.249, with a 90% ID and 
60% minimum length threshold. Sequences flanking the ARG genes detected by Resfinder were examined with 
BLAST50 to ascertain whether the sequences were phage or bacterial. The search for 16S rDNA sequences was 
performed with Kraken2 with GreenGenes supported database (13_8) taking into account the contigs generated 
by Spades. To exclude contamination from the reagents used for metagenomic analysis51, negative controls were 
performed using negative samples that were processed in parallel and used the same DNA extraction protocol 
than the viromes presented in this study.
Removal of phages from the sample. To evaluate phage removal and bacterial recovery, urine, ascitic 
fluid and serum samples were spiked with 102 CFU/mL of E. coli strain WG5 or P. aeruginosa strain PA14 and 
with 105 PFU/mL of phages that infect each strain (isolated from sewage). The spiked samples were divided in 
2 aliquots of 10 mL, one remained untreated and the other was filtered through 0.45 μm low-protein-binding 
polyvinylidene fluoride (PVDF) membranes (DURAPORE membrane filter, Millipore) using a vacuum system 
that required from 1–5 minutes with the volumes of sample filtered in this study. Filtration step allowed bacteri-
ophages to pass through the membrane while retaining bacteria. To remove more phages, the membranes were 
washed twice with 10 mL of PBS, gently agitated, and the filtration was repeated. The other 10 mL-aliquot was 
processed without filtration.
Bacteria retained in the filter after the filtration procedure were recovered by resuspending the membrane 
in 10 mL of PBS. The homogenate was added to 10 mL of Luria Broth (LB) 2-fold concentrated. In parallel, the 
non-filtered aliquot (10 mL) was also added to 10 mL of LB 2×. Bacteria and phages were enumerated in both 
aliquots by growth on LB agar plates (CFU/mL) and a double agar layer1, respectively. Then, filtered (F) and 
non-filtered (NF) aliquots were incubated at 37 °C for 18 h and bacteria were enumerated on LB agar plates after 
incubation.
Molecular confirmation of phage reduction by filtration in urine, AF and serum samples was achieved by 
inoculating a suspension containing 105 PFU/mL of Stx phage (containing the Shiga toxin (stx2) gene), and the 
number of phages was evaluated by qPCR analysis of the stx2 gene52.
qpcR procedures. qPCR assays for stx and 16S rRNA genes were performed as previously described18,52 
under standard conditions in a Step One RT PCR System (Applied Biosystems). Genes were amplified in a 20 μl 
reaction mixture with the TaqMan Environmental Master Mix 2.0 (Thermo Fisher Scientific. Waltham, MA). The 
reaction contained 1 μl of the DNA sample or quantified plasmid DNA18,52. All samples were run in triplicate, as 
well as the standards and negative controls. Gene copy number (GC) was defined as the mean of the triplicate 
data obtained.
Statistical analysis. Statistical tests were performed using one-way analysis of variance (ANOVA) in the 
Statistical Package for Social Science software (SPSS v19). A p < 0.05 was used to evaluate the differences between 
filtered versus non-filtered samples.
Data availability
The metagenomic data set generated was deposited to BioProject (PRJNA590575). Data can be checked under the 
following link: https://dataview.ncbi.nlm.nih.gov/object/PRJNA590575?reviewer=g6bbejub0bdrr64b5ir5jkti3. 
The URL will expire when this BioProject is publicly-released. All data generated are available from the 
corresponding author on reasonable request.
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